Turn.bio Company
Turn Biotechnologies develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. We are focused on reprogramming the epigenome – a network of chemical compounds and proteins that control cell functions by influencing which genes are active – to restore capabilities that are often lost with age.
Funding Status:
Seed
Number Of Exists:
1-10
Investors Number:
5
Employee Number:
1-10
Last Funding Date:
Apr 28, 2021
Headquarters:
Mountain View, California, United States
Last Funding Type:
Funding Round
Founded Date:
Feb 2019
Industry:
Biotechnology, Gene therapy, Genetics, Health Care, Therapeutics
Estimated Revenue:
Less than $1M